UCLA Finds 1 Rapamycin Dose Reverses Autism-Like Changes in Adult Mice Within 2 Hours
Updated
Updated · UCLA Health · Jul 23
UCLA Finds 1 Rapamycin Dose Reverses Autism-Like Changes in Adult Mice Within 2 Hours
3 articles · Updated · UCLA Health · Jul 23
Summary
A single rapamycin dose normalized several autism-like brain and behavior changes in adult mice within about two hours, including brain overactivity, seizure susceptibility, sensory hypersensitivity and repetitive behaviors.
UCLA linked those gains to rapid functional shifts rather than structural repair: the drug reversed abnormal gene activity tied to autism, epilepsy and ion channels, especially in excitatory neurons, and appeared to rebalance mTOR-driven brain excitability.
The mice had been exposed indirectly to mild maternal inflammation during gestation, which left offspring with persistent adult abnormalities including chronic inflammation, mild brain overgrowth and disorganized brain network connectivity.
Researchers said rapamycin itself is unlikely to become a broad human treatment because the benefits were temporary, daily dosing led to tolerance over weeks, and repeated use carries toxicity risks.
The study instead points to adult brain circuitry, mTOR signaling and excitation-inhibition balance as possible therapeutic targets, suggesting some autism-related symptoms may remain modifiable in adulthood.